Ultragenyx Pharmaceutical, Inc. (RARE)
23.50
-0.38
(-1.59%)
USD |
NASDAQ |
Feb 12, 16:00
22.65
-0.85
(-3.62%)
After-Hours: 07:41
Ultragenyx Pharmaceutical Free Cash Flow : -466.39M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Johnson & Johnson | 19.70B |
| CorMedix, Inc. | 74.42M |
| Insmed, Inc. | -906.14M |
| Apellis Pharmaceuticals, Inc. | 78.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -91.42M |
| Cash from Investing (Quarterly) | 117.18M |
| Cash from Financing (Quarterly) | 0.002M |
| Free Cash Flow Per Share (Quarterly) | -0.9291 |
| Free Cash Flow to Equity (Quarterly) | -72.91M |
| Free Cash Flow to Firm (Quarterly) | -78.48M |
| Free Cash Flow Yield | -20.34% |